CPC A61K 31/4188 (2013.01) [A61K 8/19 (2013.01); A61K 8/673 (2013.01); A61K 9/0053 (2013.01); A61K 9/2086 (2013.01); A61K 9/28 (2013.01); A61K 9/2806 (2013.01); A61Q 3/00 (2013.01); A61Q 5/002 (2013.01); A61Q 7/00 (2013.01); A61K 2800/58 (2013.01)] | 27 Claims |
1. A powder composition comprising:
isolated crystalline or isolated amorphous magnesium biotinate; and
optionally a pharmaceutically acceptable vehicle, carrier, or diluent.
|